Webinar 1:

PAT or Not PAT?

22 September 2026

When Real-Time Particle-Size Analysis Creates Business Value

22 September 2026 | Two live sessions | Expert presentation and live Q&A

Real-time particle-size analysis can provide far more than additional analytical data. Applied to the right process, it can accelerate development, improve process understanding, support scale-up and validation, reduce manual analysis, and enable greater process control.

But when does PAT genuinely create enough value to justify the investment?

Looking beyond the technical benefits of PAT

One PAT investment. Different perspectives.

Formulation: richer process data
Analytics: less sample handling
Process engineering: faster optimization
Manufacturing: earlier deviation detection
Quality: better traceability and assurance
Management: shorter timelines, fewer failed batches and greater scalability

Each stakeholder sees part of the value. Few see the complete business case.

Using the NanoFlowSizer as an example, this webinar shows how real-time particle-size monitoring can:

Improve decisions
Reduce costs
Shorten timelines
Strengthen process outcomes

The key question: When is PAT simply attractive technology, and when is it a valuable business investment?

New to PAT?

Read our introduction to Process Analytical Technology and its role in process understanding and control.

Learn more about PAT

What will you learn?

During this webinar, we will discuss:

How to identify processes in which continuous particle-size data can genuinely influence decisions
How different departments perceive the value of a PAT investment
How to bring technical, operational, quality and management benefits into one business case
Where real-time monitoring can reduce manual work, development time, process risk and avoidable costs
How to distinguish between an interesting technical opportunity and a convincing investment case

Who should attend?

This webinar is relevant for professionals involved in evaluating, developing, implementing or approving PAT solutions, including:

Formulation scientists
Analytical scientists
Process development scientists
Process engineers
PAT specialists
Manufacturing and MS&T professionals
Quality and validation teams
R&D and laboratory managers
Operations managers
Scientific and technical decision-makers

Meet the speaker

Ad Gerich, CEO InProcess-LSP

Ad Gerich holds a degree in Analytical Chemistry and Chemometrics and has extensive experience in the pharmaceutical industry.

Before co-founding InProcess-LSP in 2014, he served as Director of Product Development and Process Analytical Technology at Merck.

As CEO of InProcess-LSP, he is responsible for business development, strategy and overall management, driving innovation in real-time nanoparticle size analysis.